Clinical Trial Update: Pontic Site Development Using Soft Tissue Augmentation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Pontic Site Development using Soft Tissue Augmentation for alveolar bone loss; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Bone Loss

Snippet

Sponsor: Nouran Abdulla Mater,MD | Conditions: Alveolar Bone Loss | Phase 3 | Status: UNKNOWN